Global High Content Screening Market - Industry Trends and Forecast to 2030
The global high content screening market is expected to reach USD 4,305,259.28 thousand by 2030 from USD 2,450,200.00 thousand in 2022, growing at a CAGR of 7.3% during the forecast period of 2023 to 2030.
Market SegmentationGlobal High Content Screening Market, By Product Type (Instruments, Consumables, Software, Services, and Accessories), Application (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling, and Others), Technology (Microscopy, Flow Cytometry, Mass Spectrometry, Western Blotting, ELISA, Immunohistochemistry, and Others), End User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations, Laboratories, and Others), Distribution Channel (Direct Tenders and Retail Sales), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Denmark, Netherlands, Switzerland, Sweden, Poland, Norway, Finland, Rest of Europe, Japan, China, India, South Korea, Australia, New Zealand, Singapore, Thailand, Malaysia, Vietnam, Taiwan, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, Bahrain, U.A.E., Kuwait, Oman, Qatar, Egypt, Israel, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2030
Overview of Global High Content Screening Market DynamicsDriver
• Increasing drug discovery and development activities
Restraint
• High cost associated with initial setup and maintenance
Opportunity
• The growing number of Contract Research Organizations (CROs) providing HCS services
Market PlayersSome of the major market players operating in the global high content screening market are:• BD
• Merck KGaA
• Corning Incorporated
• Carl Zeiss AG
• Sartorius AG
• EVIDENT
• Zifo RnD Solutions
• Axxam S.p.A.
• Molecular Devices, LLC. (Subsidiary of Danaher Corporation)
• Thermo Fisher Scientific Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• Yokogawa Electric Corporation
• Sysmex Corporation
• Genedata AG
• De Novo Software
• Araceli Biosciences
• Miltenyi Biotec
• Aligned Genetics, Inc.